Corporate | 16 March 2012 12:26
|
MPH Mittelständische Pharma Holding AG / Key word(s): Regulatory Approval
MPH Mittelständische Pharma Holding AG:
The company MPH Mittelständische Pharma Holding AG today informs the shareholders that the preference share is listed in the Entry Standard (Open Market) as of today. The stock exchange trading procedure does not change.
About the company MPH Mittelständische Pharma Holding AG: The Berlin based company MPH Mittelständische Pharma Holding AG has strategically concentrated its activities on growth segments in the pharmaceutical market. With pharmaceutical products based on patent-free and patent-protected active substances, which are made available through the MPH group in the therapeutic areas oncology, HIV, rheumatology, neurology and cardiovascular diseases, a contribution is made towards cost reduction in the healthcare sector. MPH Mittelständische Pharma Holding AG has been listed on the stock exchange (Open Market) in Frankfurt as of September, 1, 2009. Within the Open Market a segment change – from First Quotation Board to Entry Standard – took place as of March, 16, 2012.
Key capital market data for MPH Mittelständische Pharma Holding AG:
Contact:
End of Corporate News 16.03.2012 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
| 160960 16.03.2012 |